What is the 13F Pro Quality Score for MLAB?

13F Pro ranks MESA LABORATORIES INC /CO/ (MLAB) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View MLAB's current score at https://13fpro.ai/research/MLAB (free sign-up required for the full ranking).

Which hedge funds own the most MLAB stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of MLAB include Long Path Partners, BlackRock,, Boston Partners. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/MLAB as soon as new 13F filings post.

Where does 13F Pro source MLAB data?

All MESA LABORATORIES INC /CO/ fundamentals and ownership data come directly from SEC EDGAR. MESA LABORATORIES INC /CO/ files with the SEC under CIK 724004. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is MLAB in?

MESA LABORATORIES INC /CO/ (MLAB) is classified in the Technology sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/technology.

How often is MLAB research updated on 13F Pro?

MLAB's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

MESA LABORATORIES INC /CO/(MLAB)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Technology →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 724004 MLAB stock profile & AI dashboard →

13F Pro Quality Score

57.9/100

Rank #1,016 of 2,879 stocksTOP 50%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

85.5/100

Profitability

55.5/100

Balance Sheet

58.1/100

Earnings Quality

30.0/100

Free Cash Flow

73.0/100

Institutional Flow

71.6/100

Revenue Scale

26.2/100

Dilution Risk

21.0/100

MLAB Stock Analysis & AI Quality Score

AI stock analysis and institutional research for MESA LABORATORIES INC /CO/ (MLAB), a Technology sector company. 13F Pro's AI-powered ranking engine scores MLAB at 57.9/100 on a 32-signal composite quality model, placing it at rank #1,016 of 2,879 stocks — the top half of the AI-ranked universe. MLAB scores in the top quartile across revenue growth (85.5). Areas of concern include revenue scale (26.2) and earnings quality (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 21.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2026), MESA LABORATORIES INC /CO/ reports quarterly revenue of $63.7M, net income of $-4.1M, an operating margin of 4.3%. Top institutional holders of MLAB by reported 13-F value include Long Path Partners, BlackRock,, Boston Partners, based on the most recent SEC filings. MLAB trades on the Nasdaq exchange and files with the SEC under CIK 724004. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MLAB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MESA LABORATORIES INC /CO/ directly from SEC EDGAR. MESA LABORATORIES INC /CO/'s 13F Pro composite quality score has ranged between 42 and 58 since 2021, currently 57.9 — an improving long-term trajectory across 28 quarterly and live scoring snapshots.

✦

Fun facts about MESA LABORATORIES INC /CO/

Quirks, history, and lore behind MLAB — the kind of stuff that makes a stock memorable.

1
The Basics
Small-cap instrumentation company · listed on Nasdaq · headquartered in Colorado · serves highly regulated industries where tiny measurement errors can be catastrophic.
2
The Numbers
Annual revenue in the low hundreds of millions of dollars — not flashy, but the business runs on recurring calibration and service contracts that keep margins healthy.
3
The History
Founded in the 1980s in the Denver area, it grew largely through acquisitions, stitching together a portfolio of niche test-and-measurement businesses that bigger players ignored.
4
The Secret
Its four core divisions cover gas flow, sterilization validation, pipette calibration, and quality control for pharmaceutical and industrial clients — not exactly dinner-party conversation, but regulators demand it.
5
The Lore
Pharmaceutical manufacturers literally cannot ship a drug batch without the kind of biological indicators and quality assurance testing this company provides — invisible to consumers, indispensable to the supply chain.
6
The Giveaway
Ticker MLAB, based in Lakewood, Colorado — this company makes sure your pipette measures accurately and your autoclave actually sterilized what it was supposed to.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q4 2026

$63.7M

Net Income

Q4 2026

$-4.1M

Free Cash Flow

Q4 2026

$13.5M

Operating Margin

Q4 2026

4.3%

ROIC

Q4 2026

1.1%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+3.4% YoY

$249.1MFY 2026

FY23 $219.1MFY24 $216.2MFY25 $241.0MFY26 $249.1M

Net Income

+440.0% YoY

$6.7MFY 2026

FY23 $930.0KFY24 $-254.2MFY25 $-2.0MFY26 $6.7M

Operating Income

+13.3% YoY

$18.5MFY 2026

FY23 $3.3MFY24 $-272.1MFY25 $16.3MFY26 $18.5M

EPS (Diluted)

+436.1% YoY

$1.21FY 2026

FY23 $0.17FY24 $-47.20FY25 $-0.36FY26 $1.21

Total Assets

-1.3% YoY

$427.7MFY 2026

FY23 $661.8MFY24 $446.8MFY25 $433.3MFY26 $427.7M

Total Debt

-5.3% YoY

$67.5MFY 2026

FY23 —FY24 —FY25 $71.3MFY26 $67.5M

Op. Cash Flow

-8.5% YoY

$42.8MFY 2026

FY23 $28.0MFY24 $44.1MFY25 $46.8MFY26 $42.8M

Metric	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	$249.1M +3.4%	$241.0M +11.5%	$216.2M -1.3%	$219.1M +18.8%	$184.3M +37.6%	$133.9M
Net Income	$6.7M +440.0%	$-2.0M +99.2%	$-254.2M -27438.3%	$930.0K -50.3%	$1.9M -42.9%	$3.3M
Operating Income	$18.5M +13.3%	$16.3M +106.0%	$-272.1M -8295.0%	$3.3M -29.4%	$4.7M -62.0%	$12.4M
EPS (Diluted)	$1.21 +436.1%	$-0.36 +99.2%	$-47.20 -27864.7%	$0.17 -51.4%	$0.35 -45.3%	$0.64
Total Assets	$427.7M -1.3%	$433.3M -3.0%	$446.8M -32.5%	$661.8M -6.4%	$707.4M +17.6%	$601.5M
Total Debt	$67.5M -5.3%	$71.3M	—	—	—	—
Operating Cash Flow	$42.8M -8.5%	$46.8M +6.1%	$44.1M +57.7%	$28.0M -28.7%	$39.2M +5.8%	$37.1M

AI Insight: MLAB Financial Trends

Operating margin swung from -457% loss in Q1 2024 to +12% profit in Q4 2025, signaling recovery from restructuring charges.

• Operating income improved from -$271M loss (Q1 2024) to $8M profit (Q4 2025); operating margin now solidly positive.

• Operating cash flow rebounded to $19M in Q4 2025 from $13M trough in Q1 2024, despite flat revenue.

• Total debt declined steadily from $71M (Q1 2025) to $68M (Q4 2025) while equity rose from $145M to $187M.

⚠ Revenue range $56–$65M over past year shows minimal growth; Q1 2024 spike to $59M not sustained.

⚠ Operating cash flow dropped 89% from $19M (Q4 2025) to undetectable in Q1 2026; timing or working-capital shift unclear.

AI Insight: MLAB Ratio Trends

Operating margin surged from 1.0% in Q1 2025 to 12.2% in Q4 2025, while leverage steadily declined from 0.45 to 0.36.

• OpMargin expanded from 1.0% (Q1 2025) to 12.2% (Q4 2025); ROIC climbed from 1.0% to 12.5% over same period.

• Debt-to-equity ratio decreased from 0.45 (Q1 2025) to 0.36 (Q1 2026), signaling improved financial leverage.

• Net profit margin recovery: swung from -23.1% loss (Q1 2025) to consistent 4–8% profitability (Q2–Q4 2025).

⚠ Q1 2025 showed deep losses across all return metrics (NPM -23.1%, ROE -32.1%). Verify if seasonal or one-time item.

⚠ Most recent quarter (Q1 2026) lacks profitability and return data; cannot confirm margin trajectory continuation.

Get alerted when MLAB's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for MESA LABORATORIES INC /CO/ including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of MLAB

Long Path Partners LP
$35.9M405,583 sh
BlackRock, Inc.
$34.8M393,851 sh
Boston Partners
$23.8M268,711 sh
Select Equity Group, L.P.
$20.9M235,885 sh
VANGUARD CAPITAL MANAGEMENT LLC
$20.6M232,643 sh
Ranger Investment Management, L.P.
$17.9M202,903 sh
AQR CAPITAL MANAGEMENT LLC
$15.1M170,562 sh
MORGAN STANLEY
$14.3M162,116 sh
ROYCE & ASSOCIATES LP
$14.3M161,229 sh
DIAMOND HILL CAPITAL MANAGEMENT INC
$13.7M155,302 sh

Fund	Value	Shares
Long Path Partners LP	$35.9M	405,583
BlackRock, Inc.	$34.8M	393,851
Boston Partners	$23.8M	268,711
Select Equity Group, L.P.	$20.9M	235,885
VANGUARD CAPITAL MANAGEMENT LLC	$20.6M	232,643
Ranger Investment Management, L.P.	$17.9M	202,903
AQR CAPITAL MANAGEMENT LLC	$15.1M	170,562
MORGAN STANLEY	$14.3M	162,116
ROYCE & ASSOCIATES LP	$14.3M	161,229
DIAMOND HILL CAPITAL MANAGEMENT INC	$13.7M	155,302

More Technology Companies

View all Technology →

AGILENT TECHNOLOGIES, INC.

AAOI

APPLIED OPTOELECTRONICS, INC.

AAPL

Apple Inc.

ABNB

Airbnb, Inc.

ACCL

Acco Group Holdings Ltd

ACCS

ACCESS Newswire Inc.

ACFN

ACORN ENERGY, INC.

ACIW

ACI WORLDWIDE, INC.

Put MLAB on your watchlist

Track score changes the day MESA LABORATORIES INC /CO/ files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is MLAB a good stock to buy?

13F Pro's AI-powered analysis of MESA LABORATORIES INC /CO/ (MLAB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MLAB are available on the MLAB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own MLAB?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MLAB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MESA LABORATORIES INC /CO/'s investment landscape.